Sino Medical Sciences Technology Inc. (SHA:688108)

China · Delayed Price · Currency is CNY

15.47

+0.15 (0.98%)

Sep 14, 2026, 11:29 AM CST

SHA:688108 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	589.57	525.41	458.74	343.26	192.85	194.36
Revenue Growth	21.43%	14.53%	33.64%	77.99%	-0.77%	-40.64%
Gross Profit	405.29	344.51	266.1	197.62	107.21	134.11
Operating Income	110.65	55.13	-34.98	-74.99	-222.45	-166.1
Net Income	83.77	47.29	1.5	-39.63	-162.38	-130.77
Earnings Per Share	0.20	0.11	0.00	-0.10	-0.40	-0.32
EPS Growth	644.59%	2650.00%	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	495.92
Overseas	29.33
Total	525.25

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	430.32	396.41	291.67	188.64	203.42	287.76
Total Debt	151.32	211.73	225.11	199.49	58.31	44.27
Net Cash (Debt)	279.01	184.68	66.56	-10.85	145.11	243.48
Net Cash Growth	203.63%	177.44%	-	-	-40.40%	-55.31%
Net Cash Per Share	0.68	0.43	0.18	-0.03	0.36	0.60

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	203.58	161.87	131.24	56.84	-111.31	-60.13
Capital Expenditures	-33.85	-45.8	-70.02	-67.67	-110.76	-158.45
Free Cash Flow	169.73	116.07	61.22	-10.83	-222.07	-218.58
Free Cash Flow Growth	67.53%	89.59%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	68.74%	65.57%	58.01%	57.57%	55.59%	69.00%
Operating Margin	18.77%	10.49%	-7.63%	-21.84%	-115.35%	-85.46%
Pretax Margin	19.10%	13.03%	-3.74%	-19.77%	-114.77%	-83.92%
Profit Margin	14.21%	9.00%	0.33%	-11.54%	-84.20%	-67.28%
FCF Margin	28.79%	22.09%	13.35%	-3.16%	-115.15%	-112.46%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	74.78	169.28	2694.18	-	-	-
Forward PE	85.11	178.98	81.33	70.82	70.82	64.39
P/FCF Ratio	37.72	68.96	65.91	-	-	-
PS Ratio	10.86	15.24	8.80	14.99	12.14	17.32